 |
|
Diabetic Nephropathy
Gerald C. Groggel, MD
Arch Fam Med. 1996;5(9):513-520.
Abstract
Diabetic nephropathy is an important microvascular complication of both insulindependent and non-insulin-dependent diabetes mellitus. It is the leading cause of end-stage renal disease. The natural course, pathogenesis, clinical evaluation, and treatment of diabetic nephropathy were reviewed, with special emphasis on recent important studies of glucose control and use of the angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy.
Author Affiliations
From the Department of Internal Medicine, University of Nebraska Medical Center, Omaha.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Heterogeneous Nuclear Ribonucleoprotein K Modulates Angiotensinogen Gene Expression in Kidney Cells
Wei et al.
J. Biol. Chem. 2006;281:25344-25355.
ABSTRACT
| FULL TEXT
Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells
Hsieh et al.
J Endocrinol 2004;183:535-550.
ABSTRACT
| FULL TEXT
End-Stage Renal Disease in People With Type 2 Diabetes: Systemic Manifestations and Exercise Implications
Evans and Forsyth
ptjournal 2004;84:454-463.
FULL TEXT
Characterization of a Putative Insulin-Responsive Element and Its Binding Protein(s) in Rat Angiotensinogen Gene Promoter: Regulation by Glucose and Insulin
Chen et al.
Endocrinology 2001;142:2577-2585.
ABSTRACT
| FULL TEXT
|
